CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Maravai Life Sciences Inc. - MRVI CFD

9.58
4.2%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.06
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Maravai LifeSciences Holdings Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 10
Open* 9.99
1-Year Change* -60.23%
Day's Range* 9.26 - 9.99
52 wk Range 9.20-26.55
Average Volume (10 days) 2.65M
Average Volume (3 months) 50.54M
Market Cap 2.78B
P/E Ratio 12.91
Shares Outstanding 251.02M
Revenue 543.92M
EPS 0.86
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Oct 31, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 22, 2023 9.58 -0.38 -3.82% 9.96 10.04 9.25
Sep 21, 2023 10.00 0.03 0.30% 9.97 10.12 9.84
Sep 20, 2023 9.93 -0.08 -0.80% 10.01 10.17 9.92
Sep 19, 2023 10.12 0.04 0.40% 10.08 10.22 9.97
Sep 18, 2023 10.10 -0.17 -1.66% 10.27 10.36 10.06
Sep 15, 2023 10.43 0.26 2.56% 10.17 10.73 10.09
Sep 14, 2023 10.29 0.30 3.00% 9.99 10.34 9.99
Sep 13, 2023 10.03 -0.25 -2.43% 10.28 10.42 10.01
Sep 12, 2023 10.27 0.07 0.69% 10.20 10.44 10.00
Sep 11, 2023 10.40 -0.21 -1.98% 10.61 10.84 10.15
Sep 8, 2023 10.78 0.16 1.51% 10.62 11.22 10.55
Sep 7, 2023 11.07 0.53 5.03% 10.54 11.14 10.34
Sep 6, 2023 10.81 0.78 7.78% 10.03 11.12 9.98
Sep 5, 2023 10.06 -0.07 -0.69% 10.13 10.34 9.94
Sep 1, 2023 10.27 -0.08 -0.77% 10.35 10.52 10.20
Aug 31, 2023 10.32 0.12 1.18% 10.20 10.57 10.08
Aug 30, 2023 10.29 -0.05 -0.48% 10.34 10.45 10.12
Aug 29, 2023 10.39 0.04 0.39% 10.35 10.58 10.31
Aug 28, 2023 10.28 0.30 3.01% 9.98 10.56 9.92
Aug 25, 2023 10.38 0.28 2.77% 10.10 10.46 9.94

Maravai Life Sciences Inc. Events

Time (UTC) Country Event
Thursday, September 28, 2023

Time (UTC)

14:00

Country

US

Event

Maravai LifeSciences Holdings Inc To Host R&D Day
Maravai LifeSciences Holdings Inc To Host R&D Day

Forecast

-

Previous

-
Tuesday, October 31, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Maravai LifeSciences Holdings Inc Earnings Release
Q3 2023 Maravai LifeSciences Holdings Inc Earnings Release

Forecast

-

Previous

-
Tuesday, November 14, 2023

Time (UTC)

10:59

Country

US

Event

Maravai LifeSciences Holdings Inc at Jefferies London Healthcare Conference
Maravai LifeSciences Holdings Inc at Jefferies London Healthcare Conference

Forecast

-

Previous

-
Tuesday, February 20, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Maravai LifeSciences Holdings Inc Earnings Release
Q4 2023 Maravai LifeSciences Holdings Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 883.001 799.24 284.098 143.14 123.833
Revenue 883.001 799.24 284.098 143.14 123.833
Cost of Revenue, Total 168.957 140.561 79.649 66.849 60.765
Gross Profit 714.044 658.679 204.449 76.291 63.068
Total Operating Expense 308.993 244.595 171.788 119.152 113.019
Selling/General/Admin. Expenses, Total 129.259 100.064 94.245 40.354 33.194
Research & Development 15.569 9.319 1.704 3.627 4.499
Depreciation / Amortization 2.8 5.9 7.6 8 8
Unusual Expense (Income) 0.208 -11.249 -11.41 0 5.622
Other Operating Expenses, Total -7.8 0 0 0.322 0.939
Operating Income 574.008 554.645 112.31 23.988 10.814
Interest Income (Expense), Net Non-Operating -18.076 -30.26 -30.74 -29.959 -27.399
Other, Net -4.46 6.38 0.126 0.118 0.087
Net Income Before Taxes 551.472 530.765 81.696 -5.853 -16.498
Net Income After Taxes 490.663 469.25 78.816 -5.201 -16.915
Minority Interest -270.458 -287.213 13.342 2.4 4.446
Net Income Before Extra. Items 220.205 182.037 92.158 -2.801 -12.469
Net Income 220.205 182.037 92.158 -2.801 -12.469
Total Adjustments to Net Income -15.27 -5.68 -5.259
Income Available to Common Excl. Extra. Items 220.205 182.037 76.888 -8.481 -17.728
Income Available to Common Incl. Extra. Items 220.205 182.037 76.888 -8.481 -17.728
Diluted Net Income 426.276 402.356 76.888 -8.481 -17.728
Diluted Weighted Average Shares 255.323 257.803 257.621 257.621 257.621
Diluted EPS Excluding Extraordinary Items 1.66956 1.56071 0.29845 -0.03292 -0.06881
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS 1.7403 1.52746 0.27165 -0.03292 -0.05463
Dilution Adjustment 206.071 220.319
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 68.914 79.025 204.713 191.263 487.025
Revenue 68.914 79.025 204.713 191.263 487.025
Cost of Revenue, Total 43.273 33.676 53.253 38.176 77.528
Gross Profit 25.641 45.349 151.46 153.087 409.497
Total Operating Expense 80.528 76.492 95.467 74.36 139.166
Selling/General/Admin. Expenses, Total 34.677 37.971 37.203 30.095 59.761
Research & Development 4.194 4.145 4.411 5.389 7.969
Depreciation / Amortization 0.7 0.7 0.6 0.7 1.5
Unusual Expense (Income) 0 0 0 0 0.208
Operating Income -11.614 2.533 109.246 116.903 347.859
Interest Income (Expense), Net Non-Operating -0.231 -5.788 -7.842 -3.136 -7.098
Other, Net -1.519 -1.268 -5.528 -0.004 1.072
Net Income Before Taxes -13.364 -4.523 95.876 113.763 341.833
Net Income After Taxes -11.943 -1.348 87.429 99.653 303.581
Minority Interest 5.402 1.281 -49.795 -55.184 -165.479
Net Income Before Extra. Items -6.541 -0.067 37.634 44.469 138.102
Net Income -6.541 -0.067 37.634 44.469 138.102
Income Available to Common Excl. Extra. Items -6.541 -0.067 37.634 44.469 138.102
Income Available to Common Incl. Extra. Items -6.541 -0.067 37.634 44.469 138.102
Diluted Net Income -6.541 -0.067 75.161 44.487 306.628
Diluted Weighted Average Shares 131.864 131.739 131.626 131.651 193.487
Diluted EPS Excluding Extraordinary Items -0.0496 -0.00051 0.57102 0.33792 1.58475
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.03069 0.02789 0.58965 0.35893 1.63859
Total Adjustments to Net Income
Dilution Adjustment 37.527 0.018 168.526
Other Operating Expenses, Total -2.316 0 0 -7.8
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 847.902 740.039 331.598 60.552 53.802
Cash and Short Term Investments 632.138 551.272 236.184 24.7 21.866
Cash 632.138 551.272 236.184 24.7 21.866
Total Receivables, Net 146.814 117.512 51.218 18.83 15.991
Accounts Receivable - Trade, Net 138.624 117.512 51.218 18.83 15.991
Total Inventory 43.152 51.557 33.301 14.202 14.308
Prepaid Expenses 25.798 19.698 10.895 2.82 1.637
Total Assets 2282.31 1918.28 1270.69 577.796 539.676
Property/Plant/Equipment, Total - Net 116.59 95.427 101.305 94.311 42.578
Property/Plant/Equipment, Total - Gross 136.092 107.959 111.952 102.41 31.492
Accumulated Depreciation, Total -19.502 -12.532 -10.647 -8.099 -4.289
Goodwill, Net 283.668 152.766 224.275 224.275 224.275
Intangibles, Net 216.663 117.571 177.656 197.853 218.127
Other Long Term Assets, Total 817.492 812.473 435.857 0.805 0.894
Total Current Liabilities 110.144 93.777 130.778 29.562 35.919
Accounts Payable 5.991 8.154 8.171 7.478 3.604
Accrued Expenses 50.629 29.34 29.014 16.515 11.147
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.44 6 6 2.5 2.5
Other Current Liabilities, Total 48.084 50.283 87.593 3.069 18.668
Total Liabilities 1737.1 1602.78 1182.18 436.4 395.271
Total Long Term Debt 521.997 524.591 584.781 387.702 337.389
Long Term Debt 521.997 524.591 528.614 334.783 335.55
Capital Lease Obligations 0 56.167 52.919 1.839
Deferred Income Tax 0 8.609 14.697 15.856
Minority Interest 360.025 229.862 66.235 3.231 3.611
Other Liabilities, Total 744.931 754.547 391.777 1.208 2.496
Total Equity 545.218 315.499 88.511 141.396 144.405
Common Stock 2.554 2.552 2.576 183.91 182.809
Retained Earnings (Accumulated Deficit) 404.766 184.561 0.854 -42.381 -38.237
Other Equity, Total 0 -0.044 -0.133 -0.167
Total Liabilities & Shareholders’ Equity 2282.31 1918.28 1270.69 577.796 539.676
Total Common Shares Outstanding 255.361 255.157 257.621 257.621 257.621
Additional Paid-In Capital 137.898 128.386 85.125
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 765.513 847.902 835.526 759.382 619.135
Cash and Short Term Investments 628.273 632.138 617.446 550.676 431.469
Cash 628.273 632.138 617.446 550.676 431.469
Total Receivables, Net 56.889 146.814 132.224 128.929 120.355
Accounts Receivable - Trade, Net 56.273 138.624 114.069 120.354 120.355
Total Inventory 54.819 43.152 62.424 60.113 51.409
Prepaid Expenses 25.532 25.798 23.432 19.664 15.902
Total Assets 2315.39 2282.31 2248.9 2171.8 2043.23
Property/Plant/Equipment, Total - Net 87.721 116.59 102.538 94.185 47.702
Goodwill, Net 326.569 283.668 283.535 283.535 283.535
Intangibles, Net 241.578 216.663 222.899 229.153 235.405
Other Long Term Assets, Total 894.007 817.492 804.401 805.544 857.453
Total Current Liabilities 124.896 110.144 115.655 112.53 86.675
Accounts Payable 4.784 5.991 9.459 23.267 10.384
Accrued Expenses 70.065 50.629 48.181 34.581 32.411
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.74 5.44 5.44 5.44 5.44
Other Current Liabilities, Total 44.307 48.084 52.575 49.242 38.44
Total Liabilities 1793.87 1737.1 1745.14 1715.21 1660.67
Total Long Term Debt 537.73 521.997 522.824 523.655 524.499
Long Term Debt 521.161 521.997 522.824 523.655 524.499
Capital Lease Obligations 16.569
Deferred Income Tax 8.68
Minority Interest 379.121 360.025 337.908 317.204 271.743
Other Liabilities, Total 743.444 744.931 768.751 761.822 777.754
Total Equity 521.517 545.218 503.761 456.588 382.559
Common Stock 2.509 2.554 2.552 2.552 2.552
Additional Paid-In Capital 114.309 137.898 134.077 131.373 128.584
Retained Earnings (Accumulated Deficit) 404.699 404.766 367.132 322.663 251.423
Other Equity, Total
Total Liabilities & Shareholders’ Equity 2315.39 2282.31 2248.9 2171.8 2043.23
Total Common Shares Outstanding 250.883 255.361 255.209 255.208 255.159
Other Current Assets, Total
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 490.663 469.25 78.816 -5.201 -16.915
Cash From Operating Activities 535.977 368.57 152.187 24.115 -0.186
Cash From Operating Activities 7.566 6.413 5.517 3.81 2.225
Amortization 24.269 18.339 20.32 20.274 20.122
Deferred Taxes 42.318 46.904 -5.464 -1.159 0.317
Non-Cash Items 16.243 4.295 17.105 4.101 9.906
Cash Taxes Paid 23.032 22.473 5.006 -0.802 -0.097
Cash Interest Paid 20.198 27.234 28.916 28.728 25.678
Changes in Working Capital -45.082 -176.631 35.893 2.29 -15.841
Cash From Investing Activities -267.612 105.655 6.068 -17.148 -3.451
Capital Expenditures -17.09 -14.85 -25.408 -17.148 -3.611
Other Investing Cash Flow Items, Total -250.522 120.505 31.476 0 0.16
Cash From Financing Activities -187.499 -159.049 53.212 -4.167 -9.167
Financing Cash Flow Items -184.417 -154.758 -444.983 -1.527 -64.595
Issuance (Retirement) of Debt, Net -5.44 -6 196.924 -2.64 55.428
Foreign Exchange Effects 0 -0.088 0.017 0.034 -0.069
Net Change in Cash 80.866 315.088 211.484 2.834 -12.873
Issuance (Retirement) of Stock, Net 2.358 1.709 301.271
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -1.348 490.663 403.234 303.581 146.86
Cash From Operating Activities 85.074 535.977 436.642 326.583 162.304
Cash From Operating Activities 2.08 7.566 5.604 3.747 1.855
Amortization 6.765 24.269 18.033 11.779 5.527
Deferred Taxes -1.52 42.318 35.307 26.073 13.217
Non-Cash Items 10.756 16.243 3.785 0.769 3.083
Cash Taxes Paid 0.521 23.032 19.581 13.856 0.914
Cash Interest Paid 9.593 20.198 11.416 6.132 1.373
Changes in Working Capital 68.341 -45.082 -29.321 -19.366 -8.238
Cash From Investing Activities -69.73 -267.612 -249.092 -243.245 -241.584
Capital Expenditures -7.868 -17.09 -10.876 -4.409 -2.748
Other Investing Cash Flow Items, Total -61.862 -250.522 -238.216 -238.836 -238.836
Cash From Financing Activities -19.209 -187.499 -121.376 -83.934 -40.523
Financing Cash Flow Items -17.516 -184.417 -119.289 -82.477 -39.889
Issuance (Retirement) of Stock, Net -0.333 2.358 1.993 1.263 0.726
Issuance (Retirement) of Debt, Net -1.36 -5.44 -4.08 -2.72 -1.36
Foreign Exchange Effects 0 0 0 0
Net Change in Cash -3.865 80.866 66.174 -0.596 -119.803

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Maravai Life Sciences Inc. Company profile

Maravai Life Sciences Inc. provides in vitro diagnostic products, diagnostic laboratory services, and life sciences tools. The company was founded in 2014 and is based in San Diego, California.
Industry: Bio Diagnostics & Testing

10770 Wateridge Circle Suite 200
Suite 200
SAN DIEGO
CALIFORNIA 92121
US

Income Statement

  • Annual
  • Quarterly

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

Oil - Crude

90.14 Price
+0.770% 1D Chg, %
Long position overnight fee 0.0415%
Short position overnight fee -0.0634%
Overnight fee time 21:00 (UTC)
Spread 0.030

BTC/USD

26,637.75 Price
+0.210% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

ETH/USD

1,596.31 Price
+0.130% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

US100

14,710.90 Price
+0.190% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading